What are the differences in functioning, structure, and origin between Interleukin-1 (IL-1) and Tumor Necrosis Factor (TNF), and can they be considered neuropeptides?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differences Between IL-1 and TNF: Structure, Function, and Origin

Structural Differences

IL-1 and TNF are structurally distinct proinflammatory cytokines that belong to different protein families and have fundamentally different molecular architectures. 1

  • TNF-α exists in two biologically active forms: a transmembrane precursor (tmTNF) and a soluble cytokine (sTNF) released after cleavage from the cell surface 1
  • IL-1 exists primarily as two isoforms (IL-1α and IL-1β), both approximately 17 kD proteins that function as soluble mediators 1, 2
  • TNF-α binds to two distinct receptors: TNF receptor 1 (TNFR1, p55) and TNF receptor 2 (TNFR2, p75), leading to NF-κB activation and/or cell apoptosis 1
  • IL-1 binds to its specific IL-1 receptor, which can be blocked by interleukin-1 receptor antagonist (IL-1Ra) at high concentrations 3

Cellular Origin and Production

Both cytokines are primarily produced by monocyte-macrophages, but their cellular sources extend to multiple cell types with some overlap. 2

  • TNF-α is produced by macrophages, microglia, astrocytes, neurons, endothelial cells, and keratinocytes 1
  • IL-1 (both α and β) is produced by microglia, astrocytes, oligodendrocytes, neurons, and keratinocytes 1
  • Both cytokines can be produced by the same cell types in response to inflammatory stimuli, though their production kinetics differ 3

Functional Differences

Inflammatory Response Profiles

IL-1 and TNF exhibit distinct temporal and mechanistic profiles in mediating inflammation, despite producing similar biological effects. 4

  • IL-1 induces PMN leukocyte accumulation that is slow in onset (peak at 3-4 hours), requires protein synthesis (inhibitable by Actinomycin D and Cycloheximide), and is not associated with significant plasma leakage 4
  • TNF-α induces rapid PMN leukocyte accumulation and edema formation (half-life 6-10 minutes), is PMN leukocyte-dependent but not protein biosynthesis-dependent, and causes significant plasma leakage 4
  • IL-1 plays a central role in inflammation by inducing release of inflammatory mediators, activating inflammatory cells, and up-regulating adhesion molecules on endothelial cells 1
  • TNF-α promotes leukocyte extravasation, induces fever, and promotes vasodilation 1

Shared Pathophysiological Effects

Both cytokines work synergistically to drive tissue destruction and fibrosis in chronic inflammatory diseases. 1, 2

  • IL-1 and TNF-α together induce high levels of matrix metalloproteinases (MMP) in fibroblasts, synovial cells, and chondrocytes 2
  • Both cytokines induce fibroblast collagen production and cause pulmonary fibrosis in animal models 1
  • TNF-α and IL-1 are the principal mediators of tissue destruction in immuno-inflammatory diseases such as rheumatoid arthritis 2

Kinetic Behavior During Infection

The temporal dynamics of IL-1 and TNF differ significantly during severe infections, with important clinical implications. 3

  • During fulminant septicemia, TNF plasma concentration increases only transiently during the very early stage of infection 3
  • IL-1 antigen concentration and activity increase 16-fold and 61-fold respectively during the first week, with TNF-α rising later (highest levels Days 14-28) 1
  • Peripheral blood cells cannot be stimulated to produce IL-1β during acute severe infectious diseases, while IL-1Ra production remains unaffected 3

Signal Transduction Mechanisms

Despite activating similar transcription factors and producing comparable biological effects, IL-1 and TNF utilize distinct receptor-proximal signaling pathways that converge on common downstream cascades. 5

  • Both cytokines activate the same set of transcription factors through members of the MAPKK kinase protein family 5
  • TNF receptor associated factors (TRAFs) serve as the link between receptor-proximal events and common MAPKK kinases 5
  • Different pathway-specific TRAFs are used by TNF-α and IL-1 to activate the same MAPKK kinase-controlled cascades 5

Regulatory Control

Natural inhibitors differentially regulate IL-1 and TNF activity through distinct mechanisms. 3

  • Soluble TNF receptors (sTNFR1 and sTNFR2) are shed upon inflammatory stimuli and complex circulating TNF, preventing binding to effector cells 1, 3
  • IL-1 receptor antagonist (IL-1Ra) blocks IL-1β binding to its receptor at high concentrations 3
  • Anti-inflammatory cytokines IL-4 and IL-10 suppress gene expression and synthesis of both IL-1 and TNF 6, 2
  • IL-10 considerably decreases production of IL-1, TNF-α, and metalloproteases while stimulating TIMP production 2

Are They Neuropeptides?

IL-1 and TNF are definitively NOT neuropeptides—they are cytokines with fundamentally different biochemical properties and functions. 1

Critical Distinctions

  • Neuropeptides are small signaling molecules (typically 3-40 amino acids) produced by neurons and released from nerve terminals, such as substance P, neurokinins, and BDNF 1
  • Cytokines like IL-1 and TNF are larger proteins (approximately 17 kD for IL-1, similar for TNF) produced primarily by immune cells, though they can be produced by neurons 1, 2
  • While both IL-1 and TNF have receptors on neurons and can affect neuronal function, this does not make them neuropeptides 1
  • The bioactivity of true neuropeptides is terminated by specific peptidases (NEP and DPP-IV), whereas cytokines are regulated by soluble receptors and receptor antagonists 1, 3

Neuroimmune Communication

  • IL-1 and TNF function as neuroimmune communicators rather than neuropeptides, mediating bidirectional communication between the immune and nervous systems 1
  • Both cytokines can affect the central nervous system to initiate fever and other systemic responses 7
  • Tumor-derived IL-1, IL-6, and TNF-α can affect neuroendocrine control of appetite, leading to anorexia 1
  • These cytokines represent inflammatory mediators that influence neurological function, distinct from the classical definition of neuropeptides produced by and acting primarily within the nervous system 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994

Research

Controlling the production of interleukin-1 and tumor necrosis factor in disease.

Nutrition (Burbank, Los Angeles County, Calif.), 1995

Guideline

Cytokine Functions and Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.